Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by PurpleChipson Feb 13, 2020 10:53am
218 Views
Post# 30685830

TBP Enters Into Manufacturing Agreement W/Vitiprints

TBP Enters Into Manufacturing Agreement W/Vitiprints“The previous technology used for the manufacturing process was excellent but unfortunately it was limited by its maximal batch size capacity.” said Dr. Guy Chamberland, Tetra Bio-Pharma’s CEO and Chief Regulatory Officer.  “In a first phase of implementation, Tetra’s production capacity will increase from 2,500 dosing capsules in a 3-day shift to 100,000 CAUMZ™ dosage units in a single 8-hour shift.  The second phase will involve a scale-up and transfer of this proprietary technology to a Greater Montreal Pharmaceutical facility.”

https://ir.tetrabiopharma.com/newsroom/press-releases/news-details/2020/Tetra-Bio-Pharma-Enters-into-Manufacturing-Agreement-with-Vitiprints-LLC-for-CAUMZ-and-HCC011/default.aspx
<< Previous
Bullboard Posts
Next >>